Canon 2014 Annual Report Download - page 8

Download and view the complete annual report

Please find page 8 of the 2014 Canon annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 92

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92

Canon U.S. Life Sciences, Inc., Maryland, is carrying out research
and development for a DNA diagnostic system, using applications
of CMOS sensor and inkjet printer technologies.
The Network Cameras deliver high image quality, advanced function-
ality, and high performance, while being used in various places, such
as urban areas, offi ces, and public institutions, to provide new values.
06
Seeking to realize innovation beyond the boundaries
of Japan, Canon is looking to Europe and the United
States to contribute to global growth through the cre-
ation of new business in terms of both quality and
quantity within the framework of the Three Regional
Headquarters management system. By maintaining a
highly profitable structure, we aim to join the ranks of
the world’s top 100 companies in terms of all key mea-
sures of business performance.
In the United States, Canon Virginia is preparing to
commence mass production of a DNA diagnostic system
developed by Canon U.S. Life Sciences, while in Europe,
Océ is in the process of establishing its function as our
headquarters for commercial printers.
In the meantime, we will make effective use of our
healthy cash flows to establish new businesses while pro-
moting measures to nurture and expand them. In 2014,
with the aim of expediting the development of next-gen-
eration semiconductor lithography systems, we acquired
Molecular Imprints (now Canon Nanotechnologies),
a company with expertise in nanoimprint technolo-
gies that make possible high-resolution nanolithogra-
phy processes. In addition, to secure our No. 1 position
in the global network video surveillance market, we
acquired Milestone Systems, a world-leading provider
of open platform video management software. In 2015,
we plan to acquire Axis AB, the global leader in network
video solutions.
We have also been focusing our energies on strength-
ening our MR (mixed reality) system business, enhancing
these systems that merge the real and virtual worlds in
real time. Within the medical equipment segment, we
are working to swiftly establish our remote image-diag-
nostic service business while accelerating our develop-
ment efforts in such promising areas as photoacoustic
tomography devices capable of the three-dimensional
display of blood vessels.
Developing new business through globalized diversifi cation and establishing the Three
Regional Headquarters management system
Strategy
2
TO OUR STOCKHOLDERS